Neel Heerasing - Concepedia

Author

Neel Heerasing

Royal Devon & Exeter NHS Foundation Trust ORCID

Also Known As

N Heerasing, N M Heerasing, N. Heerasing, N. M. Heerasing, N.M. Heerasing, Neel Heerasing, Neel Heerasing (13087041), Neel M Heerasing, Neel M. Heerasing, P Hendy

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Royal Devon & Exeter NHS Foundation Trust University of Exeter Royal Devon and Exeter Hospital Guy's and St Thomas' NHS Foundation Trust Monash University

About

Neel Heerasing is an author at Royal Devon & Exeter NHS Foundation Trust specializing in rheumatoid arthritis, immunology, and inflammatory arthritis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	655
2	Gastroenterology	1	1	655
3	Immunology	1	1	655
4	Clinical Epidemiology	1	1	655
5	Inflammation	1	1	655

Neel Heerasing

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study Nicholas A. Kennedy, Graham Heap, Harry Green, The Lancet. Gastroenterology & hepatology InflammationActive Luminal CrohnAnti-tnf Treatment FailureImmunologyClinical Epidemiology	2019	655
Association of Genetic Variants in <i>NUDT15</i> With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease G Walker, Graham Heap, Michiel Voskuil, JAMA	2019	167
Exclusive enteral nutrition provides an effective bridge to safer interval elective surgery for adults with Crohn's disease Neel Heerasing, Beth Thompson, Peter Hendy, Alimentary Pharmacology & Therapeutics	2017	129
Prospective population‐based cohort of inflammatory bowel disease in the biologics era: Disease course and predictors of severity Ola Niewiadomski, Corrie Studd, Jarrad Wilson, Journal of Gastroenterology and Hepatology	2015	97
<i><scp>IL</scp>28<scp>B</scp></i> genotype is not useful for predicting treatment outcome in <scp>A</scp>sian chronic hepatitis <scp>B</scp> patients treated with pegylated interferon‐α Jacinta A. Holmes, Tin Nguyen, Dilip Ratnam, Journal of Gastroenterology and Hepatology	2013	45
Faecal calprotectin effectively excludes inflammatory bowel disease in 789 symptomatic young adults with/without alarm symptoms: a prospective UK primary care cohort study G Walker, Lucy Moore, Neel Heerasing, Alimentary Pharmacology & Therapeutics	2018	39
Quality improvement project identifies factors associated with delay in IBD diagnosis G Walker, Simeng Lin, Neil Chanchlani, Alimentary Pharmacology & Therapeutics	2020	31
Could Adherence to Quality of Care Indicators for Hospitalized Patients With Cirrhosis-Related Ascites Improve Clinical Outcomes? Suong Le, Tim Spelman, Chia-Pei Chong, The American Journal of Gastroenterology	2016	30
Incidence and prevalence of inflammatory bowel disease in Devon, UK Benjamin Hamilton, Harry Green, Neel Heerasing, Frontline Gastroenterology	2020	30
Root‐cause analyses of missed opportunities for the diagnosis of colorectal cancer in patients with inflammatory bowel disease Claire Gordon, Desmond Chee, Benjamin Hamilton, Alimentary Pharmacology & Therapeutics	2020	26

Page 1